ATOM · Atomera Incorporated — research history
Complete research history. Every dossier, draft, kill, publish, and lesson the system has produced on ATOM. Public so users can audit, AI can re-reference. Live price refreshes every 60s.
About ATOM · Atomera Incorporated
Atomera Incorporated engages in the developing, commercializing, and licensing proprietary processes and technologies for the semiconductor industry in North America and Europe. The company's lead technology is the Mears Silicon Technology, a thin film of reengineered silicon that can be applied as a transistor channel enhancement to CMOS-type transistors. Its customers include foundries, integrated device manufacturers, fabless semiconductor manufacturers, original equipment manufacturers, wafer manufacturers, and electronic design automation companies. Atomera Incorporated was formerly known as Mears Technologies, Inc. and changed its name to Atomera Incorporated in January 2016. The company was incorporated in 2001 and is headquartered in Los Gatos, California.
Live Quote
HOLD (score -1) · 12-1 mom 65.6% · RSI 43 · above_200_only · -37.8% from high
Targets blend Wall Street consensus (1 analysts: low $10.00 / mean $10.00 / high $10.00) with chart-derived floors and ceilings.
1-Year Chart · RSI · MACD
Research Timeline
Newest first. Each entry shows what stage produced it, the verdict/decision, and the reasoning.
Atomera is a pre-revenue semiconductor IP licensing company that has surged ~77% YTD from October 2025 lows ($2) to current $8.17, driven by AI/semiconductor momentum rather than business milestones. The investigation trigger was met — 10 Form 4 filings in 14 days — but detailed inspection reveals they are almost exclusively option-exercise-plus-tax-withholding sales (all via pre-scheduled Rule 10b5-1 plans). Only one insider made genuine open-market purchases: CFO Francis Laurencio acquired ~$183K of stock at $3.90-$7.01 and sold at $9.44 on June 15, but this was exercise-motivated rather than a discretionary conviction buy. The company has $41M in cash, burns ~$6M/quarter with only $11K Q1 revenue, and relies on ATM equity raises to fund operations — creating material dilution risk that the recent price run partially obscures. No asymmetric long setup exists: fully priced at 52w highs relative to fundamentals, no commercial license conversion catalyst imminent, and elevated IV makes income strategies unattractive.
Recent news from TradeBytes mentioning ATOM
Articles from the sister news site that name this ticker. Independent of the AI pipeline's research.